Abstract
Coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies (CHIME) syndrome is a very rare autosomal recessive neuroectodermal disorder related to PIGL gene mutations. Here, we report a patient who showed an initial delay in psychomotor development and skin abnormalities consistent with CHIME syndrome but with atypical clinical features and laboratory findings. In line with our clinical suspicion, the c.500T>C, p.(Leu167Pro) variant (found in all the previously described cases of CHIME syndrome) was found on the paternal allele. A novel “likely pathogenic” PIGL missense variant (c.154G>A, p.(Asp52Asn)) was detected on the maternal allele. This case provides new insights into the clinical spectrum of CHIME syndrome and highlights the potential for phenotypic/genotypic variations.
Keywords: case report, CHIME syndrome, neuroectodermal disorder, PIGL
1. INTRODUCTION
Coloboma, congenital heart disease, ichthyosiform dermatosis, mental retardation, and ear anomalies (CHIME) syndrome is a very rare autosomal recessive neuroectodermal disorder that was initially described by Zunich and Kaye in 1983. 1 This disease entity is related to pathogenic variants in the gene coding for the phosphatidylinositol glycan anchor biosynthesis class L (PIGL) protein (OMIM #280000), an enzyme located at the membrane of the endoplasmic reticulum. PIGL catalyzes the second step in glycosylphosphatidylinositol (GPI) biosynthesis, that is, the de‐N‐acetylation of N‐acetylglucosaminyl‐phosphatidylinositol. 2 GPI has a critical role in the anchoring of many membrane proteins, some of which are involved in neurogenesis. 3
To date, only eight cases of CHIME syndrome in people with confirmed PIGL variants have been reported. 4 , 5 , 6 Given the rarity of this syndrome, data on its clinical features and clinical spectrum are scarce. All six of the cases reported by Ng et al. 4 carried a compound heterozygous variant c.500T>C, p.(Leu167Pro). A second pathogenic variant was identified in 5 of the 6 patients. 4 In the seventh case of PIGL‐related CHIME syndrome (reported by Knight Johnson et al. 5 ), the c.500T>C, p.(Leu167Pro) variant was again detected on the first allele but the second allele carried an intragenic deletion of PIGL's exons 4–6. In the eighth case (reported by Ceroni et al. 6 ), the c.500T>C, p.(Leu167Pro) variant on the first allele was combined with an 802 base‐pair deletion (involving the 5' untranslated region and the first 50 amino acids of PIGL) on the other allele.
Here, we report on a new case of genetically confirmed PIGL‐related CHIME syndrome with an uncommonly mild phenotype and a novel PIGL variant.
2. CASE REPORT
In November 2014, a 2‐year‐old boy was referred for the assessment of orange‐colored skin lesions. He was the second son of healthy, non‐consanguineous parents. Both parents were tall (height: 187 cm for the father and 176 cm for the mother) but had a normal body weight (73 and 58 kg, respectively) and a normal head circumference (56.5 and 54 cm, respectively). The family's medical history was otherwise unremarkable, and the boy's older brother was healthy, with normal growth parameters (height and weight).
The patient was being followed by the genetics department after the antenatal diagnosis of nephromegaly, hydramnios, and macrosomia. It is noteworthy that the antenatal karyotype was normal. The boy was born full‐term, with a birth weight of 4550 g (99th percentile), length of 52 cm (97th percentile), and head circumference of 38 cm (99th percentile). A clinical examination soon after birth revealed hepatomegaly and macroglossia. The antenatal diagnosis of nephromegaly was confirmed postnatally using ultrasound. Delayed psychomotor development and febrile seizures were diagnosed at the age of 3 months. Although language acquisition and communication skills were normal at 15 months of age, the delay in motor development was more persistent. He started to walk at the age of 22 months and was able to run at 3.5 years. Throughout his childhood, he suffered from frequent gastrointestinal, upper respiratory, and pulmonary viral infections. Screening for primary immunodeficiency (a complete blood count and immunophenotyping of circulating lymphocytes) was normal. Beckwith–Wiedemann syndrome was initially suspected but was not confirmed by molecular analysis (i.e., no abnormal methylation patterns in the 11p15 region in blood and skin samples, and normal array CGH findings). Furthermore, the ocular, ear, nose, and throat (ENT), and cardiac abnormalities usually observed in Beckwith–Wiedemann syndrome were not present. Liver function tests were normal, and in particular, alkaline phosphatase (ALP) value was measured at 311 IU/L, within the normal range (142–335).
A dermatologic examination revealed ichthyosiform changes, with xerosis and eczema on the cheeks and keratotic, follicular papules on the knees.
The examination of the skin at age 5 years revealed koilonychia, internal epicanthal folds, slowly growing, sparse, thin eyebrows, and reduced hair density on the temporoparietal scalp (Figure 1A–C). The examination of the mouth showed gingival hypertrophy and conical, irregularly spaced teeth. These clinical features were strongly consistent with a diagnosis of ectodermal dysplasia.
FIGURE 1.

Cutaneous features characteristic of CHIME syndrome: (A) Thin eyebrows and internal epicanthal folds, at age 9 years. (B) Slowly growing, sparse, thin hair, with reduced density on the temporoparietal scalp and an area of hypotrichosis at the junction of the vertex and the upper parietal scalp, at age 9 years. (C) Conical, irregularly spaced teeth, at age 5 years
The patient's neurologic impairments became less severe with age, and the delay in psychomotor development eventually disappeared. Antiepileptic medication was discontinued at the age of 6 years, with no clinical relapse. Growth parameters exceeded normal values: at 6 years of age, the boy weighed 26.5 kg (+2 standard deviations [SD]), was 126 cm tall (+2 SD), and had a head circumference of 56 cm (+3 SD).
At age 7 years, exome sequencing revealed two heterozygous, missense variants in PIGL in a compound heterozygous state (NM_004278.4). The paternal allele carried the missense variant c.500T>C, p.(Leu167Pro), already classified in the ClinVar database as “pathogenic” 4 , 5 , 6 (class 5 according to the American College of Medical Genetics (ACMG) classification 7 ). The maternal allele carried the missense variant c.154G>A, p.(Asp52Asn), which had not previously been described in the GnomAD and ClinVar databases. This variant affects a residue that is highly conserved across species (from yeast up to man) and is predicted to have a deleterious effect on protein function by various in silico prediction tools (Align GVGD, SIFT, Mutation Taster, and PolyPhen, accessed through Alamut Visual). Hence, this variant was classified as “likely pathogenic” (ACMG class 4 7 ). We submitted both variants to ClinVar; the accession numbers are respectively SCV001963616 for the variant c.154G>A, p.(Asp52Asn) and SCV001963617 for the variant c.500T>C, p.(Leu167Pro). The previously reported PIGL variants and the newly described variant are summarized in Figure 2.
FIGURE 2.

Reported PIGL gene variants. The green boxes correspond to the seven exons. The figure was created with Proteinpaint (https://pecan.stjude.cloud/proteinpaint)
On examination at the age of 9 years, the boy's growth had slowed: his weight was 32.4 kg (+1 SD), height was 140 cm (+1.5 SD), and head circumference was 57 cm (+3 SD). The aforementioned skin abnormalities were stable, and in particular, hair growth remained very slow. Mild perifollicular hyperkeratosis was observed under dermoscopy of his scalp, and yellow crusts and mild erythema were noted. His neurodevelopmental status and social skills were normal.
3. DISCUSSION
In this case, the genotype/phenotype correlation partially matched a diagnosis of CHIME syndrome. Along with the core features of this syndrome, other clinical signs have been described: epileptic seizures, facial dysmorphism (including a prominent forehead, hypertelorism, and epicanthal folds), widely spaced teeth, and skin, hair, and nail anomalies (such as sparse, thin hair, thick palms and soles, and migratory ichthyosis). 5 , 6 , 8 , 9 , 10 Our patient's clinical features, including early‐onset epilepsy, hair, tooth and nail abnormalities, and ichthyosiform dermatitis, were consistent with a diagnosis of CHIME. Persistent, excessive growth has also been reported in two cases of CHIME syndrome. 6 The clinical and molecular features of the eight previously reported PIGL‐related CHIME syndrome are summarized in the supplementary data (Table S1).
Our patient exhibited a mild phenotype. In particular, no ophthalmological, echocardiographic, or significant ENT anomalies were found. Furthermore, the boy's psychomotor and neurologic impairments receded with age. It is noteworthy that in a cell‐based functional assay, the c.500T>C, p.(Leu167Pro) variant was associated with a moderately but significantly lower level of GPI anchor markers, relative to other GPI deficiencies. 4 Of interest, this variant is the common denominator of the eight previously reported cases and has never been reported in a homozygous state. Given that the c.500T>C, p.(Leu167Pro) variant appears to have a small effect per se, the severity of the phenotype might be determined by the variant on the other allele. This might explain the phenotype in the present case: assuming that the effect of the p.(Asp52Asn) variant has a small impact, the combined effect of the two variants might result in a moderate clinical expression of the CHIME syndrome. Consequently, our patient's phenotype provides new data on the clinical spectrum of CHIME syndrome. It is noteworthy that PIGL gene variations are also associated with Mabry syndrome (characterized by hypotonia, seizures, intellectual disability, and increased blood levels of tissue nonspecific alkaline phosphatase), which is phenotypically distinct from CHIME syndrome. 3 , 11 , 12 , 13
Our case illustrates phenotypic/genotypic variations in CHIME syndrome. Exome sequencing was particularly useful for diagnosis, widening the clinical spectrum of CHIME syndrome and enabling accurate genetic counseling. 3 , 11
CONFLICT OF INTEREST
None.
INFORMED CONSENT
Informed consent from the patient's mother was obtained to publish photographs.
Supporting information
Tab S1
ACKNOWLEDGEMENTS
The authors thank David Fraser for editorial assistance.
Rolland M, Dubourg C, Cospain A, Droitcourt C, Pasquier L. Child with a mild CHIME syndrome phenotype and carrying a novel p.(Asp52Asn) PIGL pathogenic variant in association with the previously reported p.(Leu167Pro) variant: A case report. Pediatr Dermatol. 2022;39:434–437. doi: 10.1111/pde.14969
Funding information
This research did not receive any specific funding from agencies or organizations in the public, commercial, or not‐for‐profit sectors.
Catherine Droitcourt and Laurent Pasquier are co‐senior authors.
DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available on request from the corresponding author.
REFERENCES
- 1. Zunich J, Kaye CI. New syndrome of congenital ichthyosis with neurologic abnormalities. Am J Med Genet. 1983;15(2):331‐333,335. doi: 10.1002/ajmg.1320150217 [DOI] [PubMed] [Google Scholar]
- 2. Nakamura N, Inoue N, Watanabe R, et al. Expression cloning of PIG‐L, a candidate N‐ acetylglucosaminylphosphatidylinositol deacetylase. J Biol Chem. 1997;272(25):15834‐15840. doi: 10.1074/jbc.272.25.15834 [DOI] [PubMed] [Google Scholar]
- 3. Altassan R, Fox S, Poulin C, Buhas D. Hyperphosphatasia with mental retardation syndrome, expanded phenotype of PIGL related disorders. Mol Genet Metab Reports. 2018;15:46‐49. doi: 10.1016/j.ymgmr.2018.01.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Ng BG, Hackmann K, Jones MA, et al. Mutations in the glycosylphosphatidylinositol gene PIGL cause CHIME syndrome. Am J Hum Genet. 2012;90(4):685‐688. doi: 10.1016/j.ajhg.2012.02.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Knight Johnson A, Schaefer GB, Lee J, Hu Y, del Gaudio D. Alu‐mediated deletion of PIGL in a patient with CHIME syndrome. Am J Med Genet Part A. 2017;173(5):1378‐1382. doi: 10.1002/ajmg.a.38181 [DOI] [PubMed] [Google Scholar]
- 6. Ceroni JRM, Yamamoto GL, Honjo RS, Kim CA, Passos‐Bueno MR, Bertola DR. Large deletion in PIGL: a common mutational mechanism in CHIME syndrome? Genet Mol Biol. 2018;41(1):85‐91. doi: 10.1590/1678-4685-gmb-2017-0172 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405‐424. doi: 10.1038/gim.2015.30 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Shashi V, Zunich J, Kelly TE, Fryburg JS. Neuroectodermal (CHIME) syndrome: an additional case with long term follow up of all reported cases. J Med Genet. 1995;32(6):465‐469. doi: 10.1136/jmg.32.6.465 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Tinschert S, Anton‐Lamprecht I, Albrecht‐Nebe H, Audring H. Zunich neuroectodermal syndrome: migratory ichthyosiform dermatosis, colobomas, and other abnormalities. Pediatr Dermatol. 1996;13(5):363‐371. doi: 10.1111/j.1525-1470.1996.tb00702.x [DOI] [PubMed] [Google Scholar]
- 10. Schnur RE, Greenbaum BH, Heymann WR, Christensen K, Buck AS, Reid CS. Acute lymphoblastic leukemia in a child with the CHIME neuroectodermal dysplasia syndrome. Am J Med Genet. 1997;72(1):24‐29. [PubMed] [Google Scholar]
- 11. Fujiwara I, Murakami Y, Niihori T, et al. Mutations in PIGL in a patient with Mabry syndrome. Am J Med Genet Part A. 2015;167(4):777‐785. doi: 10.1002/ajmg.a.36987 [DOI] [PubMed] [Google Scholar]
- 12. Pagnamenta AT, Murakami Y, Taylor JM, et al. Analysis of exome data for 4293 trios suggests GPI‐anchor biogenesis defects are a rare cause of developmental disorders. Eur J Hum Genet. 2017;25(6):669‐679. doi: 10.1038/ejhg.2017.32 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Mogami Y, Suzuki Y, Murakami Y, et al. Early infancy‐onset stimulation‐induced myoclonic seizures in three siblings with inherited glycosylphosphatidylinositol (GPI) anchor deficiency. Epileptic Disord. 2018;20(1):42‐50. doi: 10.1684/epd.2018.0956 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Tab S1
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author.
